Abstract
While selected pancreatic diseases may be best treated by total pancreatectomy (TP), the anticipated sequelae of pancreatic insufficiency make TP an undesirable alternative. Our aim was to determine if patients undergoing TP have a worse quality of life (QoL) than age- and gender-matched controls and poor long-term glycemic control. Ninety-nine patients undergoing TP from 1985 through 2002 were identified. The 34 survivors with no recurrent malignancy were surveyed with the Short Form-36 (SF-36), the Audit of Diabetes Dependent QoL (ADD QoL), the European Organization for Research and Treatment in Cancer Pancreas 26 (EORTC PAN 26), and our institutional questionnaire. Operative morbidity and mortality were 32% and 5%, respectively. Three late postoperative deaths (3%) were attributed to hypoglycemia. Of the 34 surviving patients, 27 (79%) agreed to participate at a mean of 7.5 years postoperatively. Seven patients had required 12 hospitalizations for poor glycemic control. Per the SF-36, two domains (role physical and general health) were decreased compared with an age- and gendermatched national population (P<.05). The ADD QoL demonstrated an overall decrease in QoL related specifically to the diabetes mellitus (P < .01), but comparison with insulin-dependent diabetics from other causes showed no significant difference in QoL. The EORTC PAN 26 instrument also showed measurable effects on QoL. Total pancreatectomy can be performed safely. QoL after TP is decreased compared with age- and gender-matched controls but not with diabetes from other causes; however, the changes are not overwhelming. TP should remain a viable option but in selected patients.
Similar content being viewed by others
References
Remine WH, Priestley JT, Judd ES, King JN. Total pancreatectomy. Ann Surg 1970;172:595–604.
Pliam MB, ReMine WH. Further evaluation of total pancreatectomy. Arch Surg 1975;110:506–512.
Cuillerier E, Cellier C, Palazzo L, et al. Outcome after surgical resection of intraductal papillary and mucinous tumors of the pancreas. Am J Gastroenterol 2000;95:441–445.
Grace PA, Pitt HA, Tompkins RK, DenBesten L, Longmire WP. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 1986;151:141–149.
Ware JE, Kosinski M, Keller SK. SF-36 Physical and Mental Health Summary Scales: A User’s Manual. Boston: New England Medical Center, 1994.
Bradley C, Todd C, Gorton T, Symonds E, Martin A, Plowright R. The development of an individual questionnaire measure of perceived impact of diabetes on quality of life: the ADD QoL. Quality Life Res 1999;8:79–91.
Fitzsimmons D, Johnson CD, George S, et al. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. Eur J Cancer 1999;35:939–941.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481.
Snedecor GW, Cochran WG. Statistical Methods, 7th ed. Ames, IA: Iowa State University Press, 1980, pp 75–78.
Mehta CR, Patel NR. A network algorithm for the exact treatment of Fisher’s exact test in RxC contingency tables. J Am Stat Assoc 1983;382:427–434.
Hollander M, Wolfe DA. Nonparametric Statistical Methods. New York: John Wiley and Sons, 1973, pp 68–75.
Kloppel G, Lohse T, Bosslet K, Ruckert K. Ductal adenocarcinoma of the head of the pancreas: incidence of tumor involvement beyond the Whipple resection line. Histological and immunohistochemical analysis of 37 total pancreatectomy specimens. Pancreas 1987;2:170–175.
Fernando-del Castillo C, Ratter DW, Warsaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995; 130:295–299.
Lambert MA, Linehan IP, Russell RCG. Duodenum-preserving total pancreatectomy for end stage chronic pancreatitis. Br J Surg 1987;74:35–39.
Trede M, Chir B, Schwall C. The complications of pancreatectomy. Ann Surg 1988;207:39–47.
WarrenKW, Poulantzas JK, Kune GA. Life after total pancreatectomyfor chronic pancreatitis. Ann Surg 1966;164:830–834.
Linehan IP, Lambert MA, Brown DC, Kurtz AB, Cotton PB, Russell RCG. Total pancreatectomy for chronic pancreatitis. Gut 1988;29:358–365.
Dresler CM, Fortner JG, McDermott K, Bajorunas D. Metabolic consequences of (regional) total pancreatectomy. Ann Surg 1991;214:131–140.
Gall FP, Muhe E, Gebhardt C. Results of partial and total pancreaticoduodenectomy in 117 patients with chronic pancreatitis. World J Surg 1981;5:269–275.
Evans JD, Wilson PG, Carver C, et al. Outcome of surgery for chronic pancreatitis. Br J Surg 1997;84:624–629.
Sakorafas GH, Farnell MB, Nagorney DM, Sarr MG, Rowland CM. Pancreatoduodenectomy for chronic pancreatitis: long-term results in 105 patients. Arch Surg 2000;135:517–525.
Massucco P, Calgaro M, Bertolino F, Bima C, Galatola G, Capussotti L. Outcome of surgical treatment for chronic calcifying pancreatitis. Pancreas 2001;22:378–382.
Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications and outcomes. Ann Surg 1997;226:248–260.
Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68–72.
Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995;221:731–733.
Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 1999;65:618–623.
Kiviluoto T, Schroder T, Karonen S, Kuusi T, Lempinen M, Taskinen M. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res 1985;17:110–115.
Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependant diabetes mellitus. N Engl J Med 1993;329:977–986.
American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2001; 24(suppl:1):S33-S43.
Barnes AJ, Bloom SR, Alberti GM, Smythe P, Alford FP, Chisolm DJ. Ketoacidosis in pancreatectomized man. N Engl J Med 1977;296:1250–1253.
MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diab Med 1993;10:238–245.
Shorr RI, Wayne RA, Daughert JR, Griffin MR. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Int Med 1997;157:1681–1686.
MacLeod KM, Hepburn DA, Frier BM. Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diab Med 1993;10:238–245.
Fitzsimmons D, Kahl S, Butturini G, et al. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN 26. Am J Gastroenterol 2005;100:918–926.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Billings, B.J., Christein, J.D., Harmsen, W.S. et al. Quality-of-life after total pancreatectomy: Is it really that bad on long-term follow-up?. J Gastrointest Surg 9, 1059–1067 (2005). https://doi.org/10.1016/j.gassur.2005.05.014
Issue Date:
DOI: https://doi.org/10.1016/j.gassur.2005.05.014